GaInN/GaN heterostructures in the cubic lattice variant have the potential to overcome the limitations of wurtzite structures as commonly used for light emitting and laser diodes. Wurtzite GaInN 0001 , suffers from large internal polarization fields, which force design compromises towards ultra-narrow quantum wells and reduced recombination volume and efficiency, particularly in the green, yellow, and red visible spectral regions. Cubic GaInN microstripes on micropatterned Si 001 , with {111} V-grooves oriented along Si 01 1 , offer a system free of internal polarization fields, wider quantum wells, and a smaller bandgap energy. We prepared 6 and 9 nm Ga 1-x In x N/GaN single quantum well structures and find the emission spectrum to be dominated by the recombination in the cubic wells. The peak wavelength ranges from 520 to 570 nm with a
An atomic-scale phase transition in heterophase epitaxy (HPE) of GaN on a 900 nm-wide v-grooved Si(001) substrate is reported. Two different incorporation mechanisms of adatoms sequentially occur for the hexagonal (h-) to cubic (c-) phase transition: orientation-and phase-dependent incorporation (ODI and PDI). Epitaxy begins with ODI that results in preferential growth of h-GaN individually aligned to opposing Si(111) facets inside a v-groove but incurs a structural instability by crystallographic mismatch at the groove bottom. This instability is relieved by an abrupt transition to c-phase, initiating from single or multiple atomic sites uniquely arranged atop the mismatch along the groove. Epitaxy proceeds with PDI that allows μm-scale c-GaN extended from these sites while suppressing growth of h-GaN. An important condition for HPE and the stability of c-GaN in further growth is derived from equilibrium crystal shape.
The initial stages of the nucleation of cubic (c-) GaN in heterophase epitaxy on a Si v-groove are investigated. Growth of GaN on a nanoscale {111}-faceted v-groove fabricated into a Si(001) substrate proceeds in the hexagonal (h-) phase that induces a secondary v-groove replicating the substrate topography with two opposing {0001} facets. The secondary v-groove is then orientationally mismatched at the junction of the h-GaN facets (h-h junction) resulting in structural instability. This instability is relieved either by the formation of voids that reduce the actual junction area or by the transition to c-phase (h-c transition) suppressing further extension of the h-h junction. The distribution of voids that is locally affected by the island growth mode of h-GaN on Si(111) and the imperfection in the groove geometry impacts the initial stage of heterophase epitaxy. Primarily, The h-c transition is observed as a non-local phenomenon; it occurs homogeneously and simultaneously along the bottom of the entire secondary groove and forms a one-dimensional (1D) seed layer except for some interruptions where the h-h junction is defected by gaps or incomplete voids. Between these interruptions, epitaxy retains a single crystal but results in a series of c-GaN nanodots on the seed layer with large fluctuation in size and spacing. The adatom incorporation observed in this heterophase epitaxy is a 1D analog to the wetting of a substrate followed by the self-assembly in conventional quantum dot epitaxy. The surface morphology of the c-GaN nanodots is governed by the faceting mostly composed of (001)and (11n)-orientations and the roughening between these facets that ultimately affect the morphology of the final top surface of the c-III-N. The interruptions interfere with the homogeneity of the h-c transition and can cause antiphase defects and mosaicity. Based on experimental results, a solution to improve these issues is proposed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.